Investors looking for a Supreme Court decision on President Donald Trump’s tariffs may now need to look at next year — but ...

The tech sector is a dominant force in the market, largely due to the widespread growth of artificial intelligence in the ...

Signs of possible trouble are cropping up again in a crucial corner of the financial market despite the Federal Reserve’s ...

Stocks could see wild swings in the last trading push of the year. Where to put your money. Investors are dumping ...

The race to become the Federal Reserve’s next chair appeared almost over just a couple of weeks ago, but it’s now back to ...

Oracle’s earnings report last week didn’t do much to soothe concerns about how the company will fund its ...

Weak retail sales and spending-averse households are pushing China toward targeted stimulus — including offering digital-yuan ...

Gold looked to notch a third straight session climb on Monday, with declines in the U.S. dollar and Treasury yields providing ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Nasdaq-listed XPeng has received approval to start testing its level 3 autonomous driving technology in the Chinese city of Guangzhou, according to people familiar with the matter. That degree of ...

Ford Motor on Monday said it would take a $19.5 billion charge as it refocuses on hybrids, slashes its electric-vehicle ...

AstraZeneca and Daiichi Sankyo got U.S. approval to expand the label of their jointly developed Enhertu drug in combination with another medicine as an initial treatment for a type of breast cancer.